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Pattern formationted Gastrulation (Tsg) and Chordin (Chd) are components of an extracellular
biochemical pathway that regulates Bone Morphogenetic Protein (BMP) activity during dorso-ventral
patterning of Drosophila and Xenopus embryos, the formation of the ﬂy wing, and mouse skeletogenesis.
Because the nature of their genetic interactions remained untested in the mouse, we generated a null allele
for Cv2 which was crossed to Tsg and Chd mutants to obtain Cv2; Tsg and Cv2; Chd compound mutants. We
found that Cv2 is essential for skeletogenesis as its mutation caused the loss of multiple bone structures and
posterior homeotic transformation of the last thoracic vertebra. During early vertebral development, Smad1
phosphorylation in the intervertebral region was decreased in the Cv2 mutant, even though CV2 protein is
normally located in the future vertebral bodies. Because Cv2 mutation affects BMP signaling at a distance,
this suggested that CV2 is involved in the localization of the BMP morphogenetic signal. Cv2 and Chd
mutations did not interact signiﬁcantly. However, mutation of Tsg was epistatic to all CV2 phenotypes. We
propose a model in which CV2 and Tsg participate in the generation of a BMP signaling morphogenetic ﬁeld
during vertebral formation in which CV2 serves to concentrate diffusible Tsg/BMP4 complexes in the
vertebral body cartilage.
© 2008 Elsevier Inc. All rights reserved.Introduction
Pattern formation in the developing embryo is controlled by
gradients of morphogens in which localization, local concentration,
and binding to receptors must be precisely regulated. Extracellular
protein–protein interactions ultimately determine how much signal is
sensed by a cell at a speciﬁc position and its behavioral responsewithin
a morphogenetic ﬁeld. The Bone Morphogenetic Protein (BMP) family
of morphogens is involved in many developmental processes ranging
from dorso-ventral patterning (De Robertis and Kuroda, 2004; Little
andMullins, 2006) to organogenesis and skeletal development (Hogan,
1996; Massague and Chen, 2000; Zhao et al., 2002). Central to the
establishment of BMP morphogenetic gradients are the secreted BMP-
binding proteins Chordin (Chd), Chordin-like-1 (Chdl-1), Chordin-like-
2 (Chdl-2), Noggin, Twisted Gastrulation (Tsg) and Crossveinless-2
(CV2). Chd, Tsg and CV2have been reported to function both as pro-and
anti-BMPs depending on the model system studied (Little and Mullins,
2006; Oelgeschläger et al., 2000; Scott et al., 2001; Eldar et al., 2002;
Nosaka et al., 2003; Coles et al., 2004; Petryk et al., 2004; Zakin and De
Robertis, 2004; Ikeya et al., 2006; O'Connor et al., 2006; Zhang et al.,
2007). Chdl-1 (Cofﬁnier et al., 2001; Nakayama et al., 2001) and Chdl-2De Robertis).
l rights reserved.(Nakayama et al., 2004; Zhang et al., 2007) are molecules that function
as BMP antagonists in combinationwith Tsg, behaving similarly to Chd.
The Chordin system is regulated by the Tolloid family of metallopro-
teinases that inactivate Chd by proteolytic cleavage and release
previously inactive BMPs, which are then able to signal (Piccolo et al.,
1997; Larrain et al., 2001).
Cv2 was ﬁrst identiﬁed in Drosophila as a gene required for the
formation of the wing crossveins, structures that require high BMP
signaling (Conley et al., 2000; O'Connor et al., 2006; Blair, 2007).
Mouse CV2 contains 5 cysteine-rich (CR) domains (also found in
Chd, which function as BMP-binding modules) (De Robertis and
Kuroda, 2004), a partial Von Willebrand Factor-D domain (vWFD), a
trypsin inhibitor-like (TIL) domain involved in protein–protein
interactions and/or oligomerization (Cofﬁnier et al., 2001), and a
heparin/extracellular matrix binding site within the vWFD domain
that is thought to limit CV2 diffusion (Rentzsch et al., 2006; Serpe
et al., 2008). The amino terminal domain of CV2 binds BMP,
blocking the sites that are recognized by BMP receptors type I and
II, thus preventing signaling (Zhang et al., 2008). One difference
with Chd is that the Cv2 gene product is constitutively secreted as
two disulﬁde-linked fragments generated by an auto-catalytic
cleavage occurring in the secretory pathway (Binnerts et al., 2004;
Serpe et al., 2008; Ambrosio et al., 2008). Unlike Chd, vertebrate
CV2 is completely resistant to digestion by Tolloid metalloprotei-
nases (Ambrosio et al., 2008).
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depending on the experimental situation. Anti-BMP effects were
described in vitro during the differentiation of endothelial cells
(Moser et al., 2003), osteoblasts and chondrocytes (Binnerts et al.,
2004). However, the co-transfection of Cv2, Smad1 and Bmp4 in
Cos7 cells revealed a pro-BMP activity (Kamimura et al., 2004). The
electroporation of Cv2 in the neural tube of chick embryos produced
pro-BMP phenotypes (Coles et al., 2004). In the mouse, Cv2 has been
reported to function as a pro-Bmp4 in developing embryos (Ikeya et
al., 2006). Likewise, pro-BMP effects were described in zebraﬁsh
embryos in morpholino knock-down experiments (Rentzsch et al.,
2006; Moser et al., 2007). However, potent anti-BMP effects for CV2
were demonstrated in biochemical studies and in Xenopus and
zebraﬁsh overexpression experiments (Coles et al., 2004; Rentzsch
et al., 2006; Zhang et al., 2007). In Xenopus, depletion of CV2 with
morpholinos increased BMP signaling and strongly synergized with
the depletion of the BMP antagonist Chd, indicating that the overall
function of CV2 in early development is to inhibit BMP signaling
(Ambrosio et al., 2008). Like Chd, CV2 binds directly to Tsg protein,
which greatly increases its BMP inhibitory activity (Ambrosio et al.,
2008).
In the ﬂy wing, CV2 functions as a co-factor for Dpp/BMP that may
concentrate the activity of this ligand in the crossvein. First, Dpp/Gbb
BMP ligands form a diffusible complex with Sog/Chd and the dTsg-2/
Cv-1 protein (Vilmos et al., 2005; Shimmi et al., 2005), and are
subsequently released at the crossvein for signaling after cleavage of
Sog by the Tolloid-related metalloproteinase Tlr (Ralston and Blair,
2005; Blair, 2007). Recent work by Serpe et al. (2008) has shown that
CV2 also acts as a co-receptor that binds to Thickveins (Tkv, a Type I
BMP receptor), facilitating BMP signaling at intermediate CV2
concentrations and inhibiting signaling at high CV2 concentrations.
In the Drosophilawing, the CV2 secreted protein binds to the glypican
Dally and stays locally, not signaling beyond one or two cell diameters
from its site of synthesis (Serpe et al., 2008).
In the Xenopus gastrula, CV2 is expressed in the ventral (high-BMP)
center. Biochemical studies have shown that mouse CV2 binds with
high afﬁnity (1 nM) to Chd protein, and even more strongly to Chd/
BMP complexes or to Chd fragments resulting from cleavage of Chd by
tolloids (Ambrosio et al., 2008). This led to the proposal that the pro-
BMP effects of CV2 are caused by directing the ﬂow of Tsg/Chd/BMP
complexes towards more ventral regions in which CV2 is tethered to
the cell surface (Ambrosio et al., 2008; Bier, 2008). The ﬂow of BMP4
from dorsal toward ventral regions has been observed directly in the
Xenopus gastrula, and shown to require endogenous Chd (Ben-Zvi et
al., 2008). We now propose that a similar ﬂow of Tsg/Chd/BMP4
toward prevertebral cartilage regions expressing CV2 protein at their
surface might explain the formation of a BMPmorphogenetic gradient
during mammalian vertebral development.
In the present study we investigated the role of Cv2 during
mouse embryogenesis and its interactions with Chd and Tsg in
controlling BMP signaling using mouse loss-of-function mutations.
To analyze Cv2 function in vivo, we inactivated the Cv2 gene,
characterized the mutant phenotype, and crossed heterozygous mice
with the Chd (Bachiller et al., 2003) and Tsg (Zakin and De Robertis,
2004) mutant strains to generate compound Cv2; Chd and Cv2; Tsg
mutants. We found that Cv2−/− pups died at birth (in agreement with
Ikeya et al., 2006), of respiratory failure and displayed multiple
skeletal abnormalities. Little or no interaction between Cv2 and Chd
was observed. Surprisingly, the Cv2−/− lethality and skeletal pheno-
type were completely suppressed in Cv2−/−; Tsg−/− double mutants.
This rescue indicated that Tsg is epistatic over Cv2. The results also
indicate that Tsg, Cv2, and possibly other BMP- and Tsg-binding
proteins (such as Chdl-1, Chdl-2 and Chd), interact during skeletal
development. We propose that the function of CV2 is to generate and
maintain a BMP activity gradient in the developing vertebral
morphogenetic ﬁeld.Materials and methods
Generation of Cv2 mutant mice
Genomic DNA for Cv2 recombination arms was isolated from a
129/SVJ mouse BAC library (Incyte Genomics) and subcloned into the
pGN vector (Supplementary Fig. 1A) (Le Mouellic et al., 1990). The
plasmid was electroporated into 129/SVJ ES cells and stable
transfection was achieved after G418 selection. Clones were screened
for homologous recombination by PCR using the following primers,
CV2-5′2 (5′TCC ACC TTC TCA TTC ACA AC3′) and CV2-3′2 (5′CGG GCC
TCT TCG CTA TTA CG3′) which yielded a diagnostic band of 2530 bp
and homologous recombination was conﬁrmed by Southern Blot
(Supplementary Fig. 1B). The Cv2 mutant strain was backcrossed into
the hybrid strain B6SJLF1/J (Jackson Laboratories). The Tsg and Chd
mutant strains were previously described (Bachiller et al., 2003; Zakin
and De Robertis, 2004) and maintained in the same genetic back-
ground. The Cv2, Tsg and Chdmutant mouse strains used in this work
are publicly available from Jackson Laboratories through an agreement
made possible by the Howard Hughes Medical Institute (http://
jaxmice.jax.org, stock numbers are 007552 for Chd, 007553 for Tsg
and 007554 for Cv2).
Genotyping and RT-PCR
Genotyping of the Cv2 mutant strain was performed by PCR
(Supplementary Fig. 1A) using the following primers: pGN1 (5′ACC
CTC TGT GTC CTC CTG TTA A3′), Cv2down (5′AGT CTC CTC CTA TGT TTC
TTG C3′) and Cv2up (5′TCT CTT TGG TGA TGC TAT TGT T3′). Tsg22 (5′
AGC CTG AAT GTT TGA ATG TTT A3′), Tsg23 (5′CTT GAA TCC TTA CCT
GAATGAG 3′) and LacZ3 (5′TCT GCC AGT TTGAGG GGACGA C3′) were
used to genotype the Tsgmutant strain as previously described (Zakin
and De Robertis, 2004) and Neo2 (5′GTT CCA CAT ACA CTT CAT TCT
CAG3′), Null Low (5′GGT AGG AGA CAG AGA AGC GTA AAC T3′) and
Null Up2 (5′GAG TTA GGA GGT GGA GCT CTA CAC T3′) for the Chd
mutant strain (Bachiller et al., 2000).
For measuring transcripts by RT-PCR, the primers were RTCv2up
(5′CTC CTT CCT GAC AGG GTC TG3′) and RTCv2down (5′GGG TAC AAC
CTT TGC ATC GT3′) for Cv2, RTLacZdown (5′TTG AAA ATG GTC TGC
TGC TG3′) and RTlacZup (5′TAT TGG CTT CAT CCA CCA CA3′) for LacZ,
and HPRTforward (5′CAC AGG ACT AGA ACA CCT GC3′) and
HPRTreverse (5′GCT GGT GAA AAG GAC CTC T3′) for HPRT. They
yielded bands of 295 bp, 234 bp and 249 bp respectively.
In situ hybridization, histology, immunohistochemistry and skeletal
preparations
Procedures for in situ hybridization on whole-mount and cryostat
sections were as described (http://www.hhmi.ucla.edu/derobertis/)
using the following probes: Cv2 (Cofﬁnier et al., 2002), Tsg (Zakin and
De Robertis, 2004), Chd (Bachiller et al., 2000), Chdl-1 (previously
designated as Neuralin 1, Cofﬁnier et al., 2001), Chdl-2 (Genbank
accession number AF 338222), and Bmp1/Tll1 (Scott et al., 1999). Alcian
Blue/Alizarin Red skeletal preparations, β-galactosidase, Hematoxylin
and Eosin (H&E) andMallory's tetrachrome stainingswere as described
(Zakin and De Robertis, 2004). For antibody staining, embryos were
ﬁxed in 4% paraformaldehyde in PBS, dehydrated, embedded in
parafﬁn, serially sectioned at 7 μm and sections processed as described
(http://www.hhmi.ucla.edu/derobertis/). Rabbit anti-pSmad1 (Cell
Signaling #9511L) and anti-CV2 (R and D AF2299) antibodies were
used at a 1:100 dilution.
Preparation of mouse embryonic ﬁbroblasts (MEFs)
MEFs were prepared as previously described (Hogan et al., 1994),
with the following modiﬁcations. 12.5 days post coïtum (d.p.c.)
Fig. 1. CV2 expression pattern at 12.5 d.p.c. and Cv2−/− phenotype. (A–A′) Detection of the CV2 protein on sagittal parafﬁn sections of wild-type and Cv2mutant mouse embryos at 12.5 d.p.c. by immunohistochemistry. Note inwild-type the CV2
protein staining in the vertebral bodies (vb). No CV2 protein is detected in Cv2−/− embryos. Asterisks indicate unspeciﬁc signals present in both wild-type and mutant embryos. bo, basioccipital bone. (B) Higher magniﬁcation view of the CV2
staining in the vertebral bodies. ivd, intervertebral disc. (B′) The CV2 signal in thyroid cartilages (tc) and tracheal rings (tr), shown at a highermagniﬁcation. (C–C′) External viewof littermates from Cv2+/− intercrosses showing shorter tails in Cv2−/−
compared to wild-type and exencephaly observed in 25% of the mutants. Inset shows a Cv2−/−mutant lacking exencephaly. (D–E′) Mallory's tetrachrome staining of sagittal parafﬁn sections of wild-type (top panels) and mutant (bottom panels)
neonates. Cv2−/− embryos die at birth of respiratory failure. Note in the thoracic region of Cv2−/− the reduction of the lumen of the trachea and the decreased distance between the vertebral column and themanubrium of the sternum (ms). Insets
show tracheas of wild-type and Cv2−/− embryos stainedwith Alcian Blue and Alizarin Red. Note that in themutant the cartilage rings that support the trachea are absent. Boxed areas are shown at highermagniﬁcation in (E) and (E′). In themutant
the collapse of the tracheal lumen (Lt) is due to the absence of the tracheal rings (tr). cns, central nervous system; cr, cricoid cartilage; h, heart; hy, hyoid bone; li, liver; m, muscle; th, thyroid cartilage; to, tongue.
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9L. Zakin et al. / Developmental Biology 323 (2008) 6–18embryos were isolated from heterozygous mouse intercrosses. After
head and viscerawere removed, individual embryos wereminced on a
petri dish, using a sterile razor blade. 5 ml of trypsin (0.05%) was
added to the minced tissue, transferred to a 15 ml falcon tube and
incubated in 5% CO2 at 37 °C for 20 min. Trypsin was subsequently
inactivated with 10 ml of DMEM/10% fetal calf serum (FCS). Cells from
a single embryo were plated on a 10 cm tissue culture dish in DMEM/
10% FCS.
Western blot analyses
Tissue or cell extracts were prepared in RIPA lysis buffer with a
cocktail of phosphatase inhibitors (Complete-EDTA free from Roche
and phosphatase inhibitor cocktail sets I and II from Calbiochem).
Total-ERK (1:1000 dilution, Cell Signaling #9102), α-tubulin (1:1000,
Calbiochem #CP06) and pSmad1 (1:1000 dilution, Cell Signaling
#9511L) antibodies were used for western blot analyses. Quantitative
analyses of the western blots in Fig. 7 and Supplementary Fig. 3 were
performed with the Li-Cor Odyssey infrared imager using anti-mouse
IRdye 680 (Li-Cor # 926-32220) and anti-rabbit IRdye 800 (Li-Cor #
926-32211) secondary antibodies at a dilution of 1:1500.Fig. 2. Pattern of expression of genes containing BMP-binding CR modules in the mouse vert
and Chd in the vertebral column of 12.5 d.p.c. embryos. In situ hybridization on cryostat secti
mRNA is expressed in the vertebral body (vb) (A, A′) while Tsg (B, B′), Chdl-1 (C, C′) and ChdResults
Disruption of the Cv2 locus results in neonatal death and skeletal
abnormalities
To investigate the role of Cv2 in vivo we generated a mutant allele
of the mouse gene by inserting the reporter gene LacZ in frame at the
initiation codon and deleting sequences between exon 1 and intron 2
(Supplementary Fig. 1). Loss of CV2 protein expression was conﬁrmed
by the absence of CV2 protein in prevertebral cartilages (compare
Figs. 1A and A′) and loss of Cv2 transcript by RT-PCR on MEFs
(Supplementary Fig. 1D). The LacZ reporter recapitulated the expres-
sion of endogenous Cv2 in the tail bud, dorsal neural tube and brain
dorsalmidline at 8.5–9.5 d.p.c. and in the branchial arches and heart at
9.5 d.p.c. (compare in Supplementary Fig. 1 panels E to E′ and F to F′).
Cv2−/− pups died at birth of respiratory failure. They displayed
major skeletal abnormalities and shorter tails in all cases, and
exencephaly with 25% penetrance (Figs. 1C–E′ and Supplementary
Fig. 2). The skeletal phenotypes were in agreement with the
expression of CV2 protein in differentiating cartilage, such as the
vertebral bodies and trachea (Figs. 1A, B and B′). The expression of Cv2ebral column. (A–D′) Cv2 is expressed in a pattern complementary to that of Tsg, Chdl-1
ons. Boxed areas in A, B, C, D are shown at higher power in A′, B′, C′, D′, respectively. Cv2
(D, D′) all co-localize in the intervertebral disc (ivd).
10 L. Zakin et al. / Developmental Biology 323 (2008) 6–18in the brain dorsal midline (Supplementary Figs. 1E, E′) correlated
with the exencephaly phenotype. Cv2−/−mutants presented a dramatic
reduction in the size of the vertebral bodies as well as neural arches of
the vertebral column (Supplementary Figs. 2A, A′, C–D′). The 13thFig. 3. Smad1 phosphorylation in the developing pre-vertebral region of Cv2−/− 12.5 d.p.c. em
type (A, C, E, G, I) and Cv2−/− (B, D, F, H) 12.5 d.p.c. embryos. (A, B) Sections stained with H&E
morphological differences between wild-type and mutant embryos in this posterior regi
(intervertebral) mesenchyme (prospective vertebral body). (G, H) Detection of phosphorylate
the condensed (intervertebral) mesenchyme (indicated by brackets in G); however, th
immunohistochemistry in sections counterstained with H&E. Note that the localization
complementary to the pSmad1 domain at this stage. (J) Summary of the expression of CV2 pr
in the posterior vertebral column. The highest levels of pSmad1 overlap with Bmp, Tsg, Chd Ch
to the domain of CV2 expression in the um (prospective vertebral body). n, notochord.thoracic vertebra displayed a posterior homeotic transformation
characterized by the loss of the 13th rib with an almost complete
penetrance (Supplementary Figs. 2C, C′). In the skull, a defective fusion
of the basisphenoid bone and reduced ossiﬁcation of the tympanicbryos (posterior, more immature regions are shown). Sagittal parafﬁn sections of wild-
. Boxed areas are shown at higher magniﬁcation below. (C–F) H&E staining revealed no
on. cm, condensed mesenchyme (prospective intervertebral disc); um, uncondensed
d Smad1 (pSmad1) by immunohistochemistry. pSmad1 was detected at higher levels in
is signal was lost in the mutant (brackets in H). (I) Detection of CV2 protein by
of the CV2 protein in the uncondensed mesenchyme (future vertebral body) is
otein compared to Bmp, Tsg, Chd, Chdl-1, Chdl-2 and TolloidmRNAs and to pSmad1 levels
dl-1, Chdl-2 and Tolloid in the cm (future intervertebral region), and are complementary
11L. Zakin et al. / Developmental Biology 323 (2008) 6–18ring were present (Supplementary Figs. 2B, B′). Many of these bone
phenotypes conﬁrm those previously reported by the group of Yoshiki
Sasai (Ikeya et al., 2006). We propose that respiratory failure is theFig. 4. Impaired vertebral body differentiation in Cv2−/− 12.5 d.p.c. embryos (anterior, more m
and Cv2−/− (B, D, F, H) 12.5 d.p.c. embryos. (A, B) Sections stained with H&E. Boxed areas are s
while the intervertebral discs (ivd) appear to be unaffected. n, notochord. (G, H) pSmad1 is
pSmad1 (brackets) is smaller than in thewild-type, reﬂecting the reduced size of the vertebra
with H&E. CV2 is present in the vb, co-localizing with pSmad1. (J) Summary of the expression
to pSmad1 levels in the anterior vertebral column. At this stage the highest levels of pSmad1
of Bmp, Tsg, Chd Chdl-1, Chdl-2 and Tolloid mRNAs in the ivd.most probable cause of the lethality, since the lumen of the trachea
(Lt) was almost inexistent, compressed between the vertebral column
and themanubrium sterni (Figs.1E–E′). This phenotypewas caused byature vertebral regions are shown). Sagittal parafﬁn sections of wild-type (A, C, E, G, I)
hown at higher power in (C, D and E, F). Vertebral bodies (vb) are smaller in the mutant,
detected at higher levels in the vb at this stage. In Cv2−/− mutants the area stained for
l body. (I) Detection of CV2 protein by immunohistochemistry in sections counterstained
of CV2 protein compared to that of Bmp, Tsg, Chd, Chdl-1, Chdl-2 and TolloidmRNAs and
co-localize with CV2 protein in the vb and are complementary to the expression domain
12 L. Zakin et al. / Developmental Biology 323 (2008) 6–18the absence of the tracheal cartilage rings that physically support the
shape of the trachea (see insets in Figs. 1D and D′) and express CV2
protein (Fig. 1B′).
Expression patterns of Cv2, Tsg, Chd and Chdl-1 in the vertebral column
To better understand the Cv2−/− phenotype, the expression domain
of Cv2was compared to those of other regulators of the BMP pathway,
such as Tsg, Chd, Chdl-1 and Chdl-2, which also bind to BMP4
(Oelgeschläger et al., 2000; Nakayama et al., 2004; Zhang et al., 2007).
In situ hybridization on sections of 12.5 d.p.c. wild-type embryos using
Cv2, Tsg, Chd, Chdl-1 (Figs. 2A–D′) and Chdl-2 (not shown) probes,
revealed that Cv2 is expressed in the future vertebral bodies while Tsg,
Chd, Chdl-1 and Chdl-2 are all expressed in the intervertebral disc
region together with Bmp4 (Zakin and De Robertis, 2004) and the
Tolloid metalloproteinase Bmp1/Tll1 (Fig. 4J and data not shown).
These expression patterns are also similar at early prevertebral stages
(data not shown). In the Drosophila wing, the expression patterns for
Cv2, Chd/Sog, Bmp/Dpp and Bmp1/Tlr are complementary: Dpp
(Decapentaplegic) is present in the longitudinal veins, Sog, Tlr, dTsg2
and Gbb (glass bottom boat, a BMP ligand) in the intervein regions, and
CV2 protein is speciﬁcally localized to the crossveins, in which BMP
signaling is maximal (Blair, 2007; Serpe et al., 2008). This suggested to
us that other proteins made at a distance, such as Tsg, or the related
proteins Chd, Chdl-1 and Chdl-2, might diffuse and interact with CV2
protein that remains anchored in the vertebral body cartilage inwhich
it is transcribed (Figs. 1B and 2A, A′).
CV2 regulates the phosphorylation state of Smad1 during vertebral
development
To determine whether Cv2 mutant phenotypes resulted from a
pro- or anti-BMP activity of CV2, the levels of phosphorylated Smad1
(pSmad1), a direct downstream effector of BMP signaling, were
analyzed in the differentiating vertebrae. Because the vertebral
column forms sequentially (starting from the anterior), we compared
in detail the histological structures, levels of Smad1 phosphorylation,
and localization of CV2 protein at anterior and posterior locations
(Figs. 3 and 4). In the posterior region of 12.5 d.p.c. embryos, the early
vertebral column anlage is subdivided into uncondensed and
condensed mesenchymes, which correspond to the future vertebral
body and intervertebral disc, respectively (Figs. 3A–F). No anatomical
differences could be found at this stage in Cv2−/− compared to wild-
type, but the peak of pSmad1 signal detected in the condensed
mesenchyme was lost in the mutant (compare Figs. 3G to H).
Surprisingly, the domain defective for Smad1 phosphorylation did
not co-localize with the domain of highest CV2 protein expression
(compare Figs. 3G to I). These results indicated that CV2 is required to
facilitate BMP signaling in a domain adjacent to, but not overlapping,
the site of CV2 expression. One possible explanation could be that in
Cv2 mutants inhibitory Tsg/Chd/BMP4 or Tsg/Chdl/BMP4 complexes
accumulate in the intervertebral region and are unable to signal. This
would be in agreement with the ﬁnding that CV2 is a potent Chordin
binding protein (Ambrosio et al., 2008) that would attract diffusing
Chd/Tsg/BMP complexes to its site of expression in the future vertebral
cartilage. These observations in the early developing vertebral ﬁeld
are summarized in Fig. 3J.
In the more developed anterior region of the 12.5 d.p.c. vertebral
column, the vertebral bodies (in which CV2 is expressed) were
reduced in Cv2−/− mutants (Fig. 4, panels C–F). The reduced vertebral
body size might be explained by the failure to concentrate Tsg/Chd/
BMP complexes in the vertebral cartilage (Ambrosio et al., 2008). The
affected vertebral bodies coincided with maximal pSmad1 levels in
both wild-type and Cv2−/− embryos. The area of pSmad1 signal was
reduced in Cv2−/− (as was the cartilage), but was still clearly detected.
At this more mature anterior level of the vertebral column, theexpression of CV2 and pSmad1 proteins co-localized (compare
Figs. 4G and I). A summary of these results is presented in Fig. 4J.
Biochemically, no signiﬁcant differences were observed in total
pSmad1 levels of whole tail extracts of wild-type and mutant 12.5 d.
p.c. embryos (Fig. 5A). This might be explained by the presence in
the tail of a heterogeneous population of multiple tissues at various
stages of differentiation, thus diluting any differences in the levels
of pSmad1.
BMP-inhibitory effects of CV2 in mutant MEFs
Because MEFs are of mesodermal origin, the same germ layer that
is affected in Cv2−/− embryos, the effect of CV2 protein on BMP
signaling was analyzed in the CV2 mutant background (Fig. 5B). Upon
addition of 0.3 or 1 nM of BMP4 to Cv2−/− MEFs, Smad1 phosphoryla-
tionwas induced in a dose-dependent manner (Fig. 5B, compare lanes
1, 3 and 5). This activation of pSmad1 was repressed by the addition of
1 nM CV2 protein (compare lanes 3 to 4 and 5 to 6). Note that CV2
inhibited BMP4 signaling even at equimolar amounts (Fig. 5B, lanes 5,
6). Similar inhibition of pSmad1 by CV2 protein was observed when
wild-type MEFs were used (not shown). Importantly, the phosphor-
ylation of Smad1 was higher in Cv2−/− MEFs compared to wild-type
after addition of BMP4 (Fig. 5C, compare lanes 5 and 6). These
experiments indicate that CV2 functions as an endogenous BMP
signaling antagonist in ﬁbroblasts in culture.
The pSmad1 staining in the developing vertebral column conﬁrms
that CV2 can have a pro-BMP activity in vivo in the future
intervertebral disc (compare Figs. 3G and H, brackets). However, this
occurs only at a distance from the CV2 protein expression site,
suggesting that the defective BMP signaling phenotype results
indirectly from a change in the activity of BMP signaling gradients.
The CV2 protein remains anchored at its site of synthesis in the
prevertebral body (Figs. 1B, 3I). In the absence of CV2 in vertebral
bodies, inhibitory Tsg/Chd/BMP complexes may remain in the
intervertebral region, resulting in the reduction in BMP signaling. In
ﬁbroblasts lacking Cv2, the response to BMP signaling was increased,
suggesting that CV2 functions cell-autonomously as a BMP antagonist.
These results may be explained through an interplay between CV2 and
other BMP regulators (such as Tsg, Chd, Chdl-1 and Chdl-2) in the
context of the ﬂow of BMP-containing protein complexes in the
developing vertebralmorphogenetic ﬁeld directed by CV2 protein (see
Discussion below).
We next analyzed pSmad1 levels in double mutant MEFs for CV2
and Chd. The response of Cv2−/−, Chd−/−, or Cv2−/−; Chd−/− MEFs to low
levels of BMP4 (0.3 nM) was increased in all cases compared to
ﬁbroblasts from their wild-type siblings (Fig. 5C, lanes 5 to 8). Upon
addition of increasing amounts of BMP4 protein, it was observed that
Cv2−/−; Chd−/− double mutant MEFs showed a stronger BMP4 signaling
response than wild-type MEFs at low BMP4 levels (0.1 and 0.3 nM)
(Fig. 5D, lanes 3–6) but responded similarly at high BMP4 levels (1 nM)
(Fig. 5D, lanes 7, 8). Please note that in all ourMEF studies the effects of
BMP4 addition on pSmad1 were analyzed after only 30 min of
addition. Thus, our experiments reﬂect the initial BMP receptor
activation and represent a direct readout of BMP4 signaling activity.
These results in mutant MEFs show that the overall function of
endogenous CV2 and Chd in ﬁbroblasts is to serve as BMP4
antagonists. This is in agreement with loss-of-function studies in the
Xenopus gastrula (Ambrosio et al., 2008).
A weak genetic interaction between Cv2 and Chd
We next investigated whether Cv2 and Chd mouse mutants
displayed genetic interactions. Mouse strains carrying the Cv2 and
Chd (Bachiller et al., 2003) mutations were crossed to generate Cv2+/−;
Chd+/− mating pairs whose progeny was subsequently analyzed in late
embryos before birth. Out of 159 embryos, all genotypes were
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Cv2+/+; Chd−/− embryos which were recovered in lower numbers than
predicted by the mendelian ratio (Supplementary Table 1). This
observation was in agreement with previous ﬁndings of early lethality
in a small percentage of Chdmutants (Bachiller et al., 2003).
Bone formation is affected in both Cv2−/− and Chd−/− mutants and
compound mutant skeletons were analyzed for possible interactions
(Figs. 5E–H). Surprisingly, no signiﬁcant effects were found in Cv2−/−;
Chd−/− double mutants; in particular the characteristic posterior
homeotic transformation of the 13th thoracic vertebra present in
Cv2−/− was unaffected by the loss of Chordin (Figs. 5E–H). Conversely,Fig. 5.Western blot analyses of Smad1 phosphorylation in whole tails, MEFs derived fromw
genetic interactions between Cv2 and Chdmutants. (A) Western blot showing comparable am
12.5 mouse d.p.c. embryos. The tail contains multiple tissues in addition to the vertebral col
Addition of puriﬁed CV2 protein to Cv2−/− MEFs inhibits Smad1 phosphorylation induced by
Chd−/− MEFs compared to wild-type ﬁbroblasts upon addition of 0.3 nM of BMP4 (compar
compared to wild-type at low amounts of BMP4 (compare lanes 3 to 4, and 5 to 6. (E–H)Gene
stainedwith Alizarin Red and cartilagewith Alcian Blue. Dorsal view of the skeletons of wild-t
Chd−/− (F) is indistinguishable fromwild-type (E). The posterior homeotic transformation indica
neural arches.the Chd mutant phenotype was unchanged by Cv2 dosage. A weak
recovery of the neural arches in the lumbar region of Cv2−/−; Chd−/−
compared to Cv2−/−; Chd+/+was observed in some embryos (Figs. 5G, H
and Supplementary Table 2), which would indicate opposing effects of
CV2 and Chd. However, given that this weak rescue was limited to the
lumbar neural arches, while the numerous other skeletal defects in
both mutants showed no change, the functional signiﬁcance of this
interaction is difﬁcult to evaluate. We propose that the lack of a
strong interaction between Cv2 and Chd in vertebral column
development may be explained by the redundant anti-BMP activity
of Chdl-1 and Chdl-2 molecules which have similar functions to Chdild-type, Cv2−/−, Chd−/− and Cv2−/−; Chd−/− treated with BMP4 protein, and lack of skeletal
ounts of endogenous Smad1 phosphorylation in tails fromwild-type, Cv2−/− and Cv2+/−
umn which is the topic of this study. No signiﬁcant differences in pSmad1 are seen. (B)
30 min treatment with BMP4. (C) pSmad1 levels are higher in Cv2−/−, Chd−/− and Cv2−/−;
e lane 5 to lanes 6–8). (D) pSmad1 response levels are higher in Cv2−/−; Chd−/− MEFs
tic interaction between Cv2 andChd in the lumbar region of the vertebral column. Bone is
ype (E), Chd−/− (F), Cv2−/− (G) and Cv2−/−; Chd−/− (H) neonates. In this region the skeleton of
ted by the loss of the 13th rib (asterisk) is present in Cv2−/− and Cv2−/−; Chd−/− embryos. na,
Table 1
Suppression of the Cv2−/− lethal phenotype by Tsg loss-of-function. Genotypes of
neonates obtained from Cv2+/−; Tsg+/− intercrosses
Genotype Number of
embryos
Observed percentage
(expected percentage)
Number of embryos with
Cv2 skeletal phenotypea (%)
Cv2+/+; Tsg+/+ 8 9 (6.25)
Cv2+/−; Tsg+/+ 12 14 (12.5)
Cv2+/+; Tsg+/− 9 10.5 (12.5)
Cv2+/−; Tsg+/− 23 27 (25)
Cv2+/+; Tsg−/− 4 5 (6.25)
Cv2+/−; Tsg−/− 8 9 (12.5)
Cv2−/−; Tsgb 5 6 (6.25) 5 (100%)
Cv2−/−; Tsgc 9 10.5 (12.5) 8 (90%)
Cv2−/−; Tsgd 8 9 (6.25) 0 (0%)
Total 86
a Cv2 skeletal phenotypes include lack of the 13th rib and deltoid tuberosity, skull
phenotype, and absence of the tracheal rings. Because defective neural arches and
shorter tails are also found in Tsgmutants, this phenotypewas not taken into account in
this table.
b All died as neonates.
c Most died as neonates.
d Some of these animals were recovered alive at day 3 post-partum; since these Cv2−/−;
Tsg−/−mutants displayed the Tsg−/− skeletal phenotypewe conclude that Tsg is genetically
epistatic over Cv2. The rescue of the Cv2−/− phenotype in Cv2−/−; Tsg−/− was found to be
statistically signiﬁcant using a chi-square test for independence (pb0.001).
14 L. Zakin et al. / Developmental Biology 323 (2008) 6–18(Nakayama et al., 2001, 2004) and are co-expressed with Chd in the
mouse (Figs. 2 and 4J). In conclusion, it is likely that uncovering a
genetic interaction between Cv2 and Chd will require simultaneous
inactivation of Chdl-1 and Chdl-2.
Mutation of Tsg suppresses Cv2 loss-of-function phenotypes, including
lethality
We next analyzed the interaction between Cv2 and Tsg in
compound heterozygous knockout mice for Cv2 (this work) and Tsg
(Zakin and De Robertis, 2004). The genotype frequencies of the
progeny of Cv2+/−; Tsg+/− intercrosses are presented in Table 1. Of 86
neonates, the Cv2+/+; Tsg−/− and Cv2+/−; Tsg−/− genotypes were obtained
at slightly lower values than expected, perhaps due to an early
lethality of Tsg−/− or to statistical error. Cv2−/−; Tsg−/− neonates were
recovered in a higher percentage than expected (9%, 6.25% expected,
n=8). More importantly, Cv2−/−; Tsg−/− pups survived, while all Cv2−/−
neonates died at birth. When Cv2−/−; Tsg−/− skeletons were analyzed,
they resembled Tsg−/− with most Cv2−/− skeletal phenotypes being
rescued (Fig. 6). In all Cv2−/−; Tsg−/− neonates normal tracheal rings
were present, probably explaining why the animals survive (compare
Figs. 6B and D). The deltoid tuberosity of the humerus (compare
Figs. 6F and H), the defects in the base of the skull (not shown),
the neural arches (compare Figs. 6N and P), and the 13th rib lost in
Cv2−/− (compare Figs. 6J and L) were all rescued in Cv2−/−; Tsg−/−
animals. We conclude from these results that CV2 function requires
Tsg, and that Tsg is epistatic to Cv2.
BMP signaling in Cv2−/−; Tsg−/− MEFs
We next tested whether Tsg was also epistatic in double mutants
MEFs (Fig. 7A). In these experiments we used quantitative infrared
Western blots using anti-rabbit pSmad1 in green for signaling and
anti-mouse α-Tubulin in red as loading control. The signal intensities
weremeasured in a Li-Cor infrared scanner, and histograms quantiﬁed
pSmad1 signaling 30 min after addition of BMP4 are shown below
each lane. Phosphorylated Smad1 levels were slightly higher in Cv2−/−
ﬁbroblasts compared to wild-type after the addition of 0.3 nM BMP4
(Fig. 7A, compare lanes 3 and 4). However, they were substantially
reduced in Cv2−/−; Tsg−/− MEFs (Fig. 7A, compare lane 2 to 3 and 4), or
in Tsg−/− single mutants (Fig. 7A, compare lane 2 to 1). Note that BMP
signaling was impaired in Tsg−/− ﬁbroblasts, demonstrating the pro-BMP effect of endogenous Tsg, and that this phenotype was dominant
in Cv2−/−; Tsg−/− mutants (Fig. 7A, see histograms for lanes 1 and 2).
To further study the interaction between Cv2 and Tsg, the activities
of these proteins was analyzed after addition to Cv2−/−; Tsg−/− MEFs
(Fig. 7B). As previously noted, addition of CV2 protein to ﬁbroblasts
inhibited BMP signaling (Fig. 7B, compare lanes 2 and 3), while the
simultaneous addition of 1 nM CV2 and Tsg lowered pSmad1 levels
even more efﬁciently (Fig. 7B, lanes 3 and 5 and histogram below). We
also tested the effect of the triple addition of CV2, Tsg and Chd proteins
to Cv2−/−; Tsg−/− MEFs (Supplementary Fig. 3). This experiment
indicated that when Chd, CV2 and BMP4 where added together, the
inhibition of Smad1 phosphorylation was stronger than that obtained
for CV2 or Chd alone (Supplementary Fig. 3, compare lane 7 to 4 and
6), indicating potent anti-BMP effects of CV2 in combinationwith Chd.
Finally, when all the components (Tsg, CV2, Chd and BMP4) were
present, the overall effect was an even stronger reduction of pSmad1
levels (Supplementary Fig. 3, compare lanes 2 and 9). In conclusion,
the effect of simultaneous addition of Chd, CV2 and Tsg to ﬁbroblasts
lacking CV2 and Tsg is to inhibit BMP signaling.
In a different experimental design (Fig. 7C), CV2 protein was
preincubated with the double mutant ﬁbroblasts for 10 min, washed,
and the supernatant replaced by medium containing BMP4 alone or
BMP4 together with Tsg protein. In this experimental situation, the
only CV2 present would be tethered to the cell surface (Fig. 7C). This
setting should mimic better the in vivo situation in which CV2 serves
as a co-receptor anchored at the cell surface (Serpe et al., 2008). While
the reduction of BMP4 signaling levels by CV2 alone was less efﬁcient
in this experimental setting (Fig. 7C, compare lanes 2 and 3), the
addition of Tsg and CV2 had a synergistic inhibitory effect on BMP4
signaling (Fig. 7C, compare lanes 3 and 5). This indicates that Tsg
protein promotes the CV2 anti-BMP activity in ﬁbroblasts, as it does in
Xenopus embryos (Ambrosio et al., 2008).
Taken together, these results lead us to propose that the CV2
secreted protein helps establish morphogenetic ﬁelds of BMP
signaling between intervertebral and vertebral regions of the
vertebral column. In mouse ﬁbroblasts, CV2 displays overall an anti-
BMP activity. In vivo, CV2 would be required, in combination with Tsg,
for the proper localization of the BMP morphogenetic signal to the
vertebral cartilage.
Discussion
This study was undertaken to understand the role of CV2, Tsg and
Chd interactions and their effect on BMP signaling during mouse
embryogenesis. It was found that Cv2 is essential for survival at birth
and for proper skeletogenesis, in agreement with independent work
of Ikeya et al. (2006).We propose that this skeletal phenotype is due to
a defective localization of the BMP signal in the developing vertebral
bodies, in which the CV2 protein is located. The most interesting
observation reported here is that the lack of Tsg rescued most Cv2−/−
phenotypes, including lethality (Fig. 6). We propose that the
phenotype caused by the loss of Cv2 is the result of changes in Tsg
activity, which functions in conjunction with other Tsg-binding
proteins, such as Chd, Chdl-1 and Chdl-2 (Oelgeschläger et al., 2000;
Nakayama et al., 2004; Zhang et al., 2007), to regulate the ﬂow of BMP
morphogenetic signals between the developing intervertebral and
vertebral regions.
The biochemical functions of CV2 in embryos
Our understanding of the function of CV2 has been advanced by
recent work (reviewed by Bier, 2008). In Xenopus, CV2 is expressed in
the high-BMP region (ventral center) of the gastrula, where it
functions as a local feedback inhibitor of BMP signaling (Ambrosio
et al., 2008). Double knockdowns of CV2 and Chd present very high
BMP signaling levels, and these suggested both proteins might
Fig. 6. Tsg is epistatic over Cv2: the loss of Tsg in Cv2−/− suppresses most of the Cv2mutant skeletal phenotypes. Skeletal preparations of wild-type (A, E, I, M), Cv2−/− (B, F, J, N), Tsg−/−
(C, G, K, O) and Cv2−/−; Tsg−/− (D, H, L, P) neonates stained with Alizarin Red and Alcian Blue. (A–D) The cervical neural arches (na) are reduced in Cv2−/− but are rescued in Cv2−/−; Tsg−/−
double mutants. The tracheal rings (tr) are missing in Cv2−/− (red asterisk in B), but the tracheal (t) cartilage develops like wild-type (A) in Cv2−/−; Tsg−/− double mutants (D). (E–H).
Cv2−/− lack the humerus deltoid tuberosity (dt), which is rescued in Cv2−/−; Tsg−/−. (I–L) The posterior homeotic transformation of T13 (black asterisks) in Cv2−/− (J) is rescued in Cv2−/−;
Tsg−/− (L); however the ossiﬁcation centers (oc) remain defective. (M–P) Side views of the lumbar region. Neural arches (na) are reduced in Cv2−/− (N) but are only mildly affected in
Cv2−/−; Tsg−/− (P), as is the case in Tsg−/− mutants (O).
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high afﬁnity, and to Chordin/BMP or Chordin digestion products by
tolloids with even higher afﬁnity (Ambrosio et al., 2008). This led to
the proposal that the pro-BMP effects of CV2 may be caused by
directing the ﬂow of Tsg/Chd/BMP complexes towards the ventral sites
of CV2 expression (Ambrosio et al., 2008). The ﬂow of BMP4 towards
more ventral regions is known to require Chd in the Xenopus gastrula
(Ben-Zvi et al., 2008). CV2 has an anti-Chd activity in Xenopus, since
CV2 depletion causes the embryo to become hypersensitive to
microinjected Chordin protein (Ambrosio et al., 2008). This suggests
that cell surface CV2 may be involved in the clearing of Chd, or Chd
degradation products, from the extracellular space. The net signaling
effect of CV2 is dependent on the activity of the metalloproteinase
Xolloid-related (Xlr) which cleaves Chd (but not CV2). In the absence
of Xlr, CV2 removes BMP/Chd complexes, presumably by endocytosis,
causing its anti-BMP effect. In the presence of Xlr, complexes of Tsg/
Chd/BMP4, perhaps already bound to CV2, are clipped by Xlr, releasing
BMP for peak signaling in the ventral side (Ambrosio et al., 2008).
In the Drosophilawing, CV2 is expressed in the crossveins, a region
of peak BMP activity (Conley et al., 2000; Blair, 2006). The CV2
secreted protein remains tethered to its site of synthesis and does not
diffuse more than two cell diameters, by virtue of its tight binding to a
GPI-tethered heparin sulfate proteoglycan (HSPG) named Dally (Serpeet al., 2008). In zebraﬁsh, CV2 also shows tight binding to HSPGs
(Rentzsch et al., 2006). Importantly, CV2 also interacts with the BMP
Type I receptor Thickveins (Tkv) (Serpe et al., 2008). This raises the
intriguing possibility that CV2 may facilitate BMP signaling by
bringing Dpp/Tsg2/Sog complexes in close proximity of BMP receptors
(Serpe et al., 2008). In mammals, we have conﬁrmed this interaction
in vitro using commercial BMPR-1a (ALK-3) and CV2 proteins (A.L.
Ambrosio and E.M.D.R., unpublished). It has been proposed that low
levels of CV2 help deliver Dpp to Tkv, whereas high CV2 levels inhibit
Dpp signaling in the crossvein (Serpe et al., 2008; Bier, 2008). Thus,
both in vertebrates and in Drosophila profound strides have been
made in unraveling how CV2, Tsg and Chd regulate the formation of
BMP gradients.
Cv2 behaves as a local BMP antagonist in MEFs
The loss of CV2 resulted in multiple abnormalities in cartilages and
bones of the skeleton (e.g. vertebrae, 13th rib, trachea, deltoid
tuberosity of the humerus and basisphenoid). These defects may
originate from the defective maturation of cartilage-producing cells
(Ikeya et al., 2006). On the one hand, these phenotypes can be
interpreted as decreased BMP signaling; in particular the loss of the
13th rib has been described in mutants for Bmp4 (Lawson et al., 1999),
Fig. 7. Western blot analyses of Smad1 phosphorylation in Cv2−/−; Tsg−/− double mutant MEFs. Signals generated by infrared conjugated secondary antibodies were detected using the Li-Cor Odyssey imager. In the bottom blot, the artiﬁcial
colors red and green correspond to signals detected at λ680 nm (anti-mouse secondary antibody against the αTubulin antibody used here as loading control) and 800 nm (anti-rabbit secondary antibody against the pSmad1 antibody),
respectively. The infrared imager system allows quantiﬁcation of the relative pSmad1 levels with respect to total protein loading and this is shown in the histograms at the bottom of the blots. (A) pSmad1 levels are reduced in Tsg−/− and Cv2−/−;
Tsg−/− MEFs when compared with Cv2−/− or wild-type ﬁbroblasts upon addition of 0.3 nM of BMP4, indicating that BMP4 signaling is impaired in the absence of Tsg (pro-BMP effect of Tsg) and that this is not affected by removal of CV2. (B)
Effects of exogenous CV2 and Tsg on BMP4 signaling in Cv2−/−; Tsg−/−MEFs. Simultaneous addition of CV2 and Tsg proteins inhibited BMP signaling more efﬁciently than CV2 alone, demonstrating that Tsg promotes the anti-BMP effects of CV2.
(C) Experiments in which CV2 was preincubated with Cv2−/−; Tsg−/− MEFs for 10 min and subsequently washed to remove excess CV2, leaving only CV2 bound to the cell surface. Note that the inhibition of BMP signaling was stronger in the
presence of Tsg preincubated with BMP4 (anti-BMP effect of Tsg).
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(Delot et al., 2003). Similarly, the loss of the deltoid tuberosity was
observed in Bmp7−/−; Bmpr1b−/− (Suzuki et al., 1996). The defects in
vertebral neural arches could be attributed to either pro- or anti-BMP
activities since they are observed in mutants for the BMP antagonist
Chd (Bachiller et al., 2003), for the pro-BMP Tsg (Zakin and De
Robertis, 2004) or for Bmp7 (Jena et al., 1997).
We have derived Cv2−/−, Cv2−/−; Chd−/−, and Cv2−/−; Tsg−/− MEFs
that will be very useful to the ﬁeld. We used these new reagents to
examine the effect of the mutations on Smad1 phosphorylation
30 min after BMP addition. In ﬁbroblasts in culture, the ﬂow of BMP
signals, as in intact embryos, should not play a functional role. When
analyzed in culture, all single and double mutants indicated that CV2
behaved as an endogenous BMP antagonist in embryonic ﬁbroblasts
(Figs. 5 and 7). This is in agreement with the effect of morpholino
depletions in Xenopus, in which Chd and CV2 are overall BMP
antagonists (Ambrosio et al., 2008). In the case of Tsg−/− ﬁbroblasts,
or Cv2−/−; Tsg−/− BMP signaling was reduced (Fig. 7A, lanes 1 and 2),
supporting a pro-BMP function of Tsg (Oelgeschläger et al., 2000;
Little and Mullins, 2006; Ambrosio et al., 2008). These results contrast
with the report that Cv2−/− MEFs had reduced expression of cartilage
markers 48 h after BMP treatment (Ikeya et al., 2006). Since our
measurements were performed 30 min after treatment we believe
they represent a more direct readout of BMP signaling. Perhaps the
results of the Sasai group are caused by binding of BMP, and Chd, to
CV2 on the cell surface with subsequent release by tolloids after 48 h
in tissue culture.
In conclusion, our Cv2−/− MEFs results as well as studies on the
Drosophila wing (Ralston and Blair, 2005; Blair, 2007; Serpe et al.,
2008) and the Xenopus gastrula (Ambrosio et al., 2008), suggest that
the pro-BMP Cv2 phenotypes may be caused by changes in BMP
distribution in morphogenetic ﬁelds. The Chd-binding activity of CV2
would help generate a BMP gradient so that peak BMP signaling
results from the diffusion of Tsg/Chd/BMP complexes from the
intervertebral region towards the vertebral body where Cv2 expres-
sion is high, serving to concentrate Tsg/Chd/BMP. Upon digestion of
Chd by tolloid metalloproteinases, the released BMPs would be able to
signal (Piccolo et al., 1997) while at low levels of tolloids CV2 would
serve as a BMP antagonist by clearing Chd complexes (Ambrosio et al.,
2008). In the Drosophila embryo, the ﬂow of Dpp-GFP towards the
dorsal midline of the Drosophila embryo has been documented (Wang
and Ferguson, 2005), and shown to require endogenous Tsg/Sog/Dpp
(Eldar 2002). Related observations have been made in Xenopus (Ben-
Zvi et al., 2008).
We now propose a model in which the ﬂow of BMP4-containing
complexes towards CV2 expressing regions establishes a vertebral
morphogenetic ﬁeld. Although not yet tested directly, CV2 in the
vertebral bodymight also concentrate theChordin-likeproteins, Chdl-1
and Chdl-2, produced in the intervertebral disc, which are also able to
bind BMP4 and Tsg.We did not observe signiﬁcant genetic interactions
between Cv2 and Chd, which may be explained by Chdl-1 and Chdl-2
activities which are redundant with Chd (Nakayama et al., 2004; Zhang
et al., 2007).
The function of Cv2 in the vertebral column requires Tsg
In Drosophila, mutations in dTsg2 (Cv1) or Cv2 produce similar
crossveinless phenotypes, indicating possible interaction between
thesemolecules (Conley et al., 2000; Shimmi et al., 2005; Vilmos et al.,
2005). In Xenopus, Tsg is strongly required for BMP signaling in Cv2-
depleted embryos (Ambrosio et al., 2008). In the mouse, we now
report a strong genetic interaction between Cv2 and Tsg during
development: all Cv2−/− skeletal phenotypes, and lethality, were
rescued in Cv2−/−; Tsg−/− animals, showing that Tsg is epistatic over
Cv2. In the absence of Tsg, BMP provides only a local signal that
manifests itself in the Tsg−/− phenotype (Nosaka et al., 2003; Petryket al., 2004; Zakin and De Robertis, 2004). In Cv2−/−; Tsg−/− double
mutants the Tsg phenotype is epistatic because the other CR domain
BMP-binding proteins- such as Chd, Chdl-1 and Chdl-2- also require
Tsg activity in order to contribute to the morphogenetic gradient.
In conclusion, the recent work in the Drosophilawing (Serpe et al.,
2008) and the Xenopus gastrula (Ambrosio et al., 2008) support the
view that CV2 functions to shape the Tsg/Chd/BMP gradient. Tsg
would be required for the expression of the Cv2 phenotype because it
is required for the ﬂow of BMP4 complexes toward sites of CV2
expression.We propose, by analogy to the cases of the crossvein of the
Drosophila wing and the Xenopus gastrula, that in the mammalian
vertebral column the CV2/Chd/Tsg/BMP/Tolloid pathway may ulti-
mately shape a morphogenetic ﬁeld of BMP signaling that determines
the choice between vertebral cartilage or intervertebral cell differ-
entiation fates. This extracellular signaling network may contribute to
the great evolutionary variability of vertebral morphology in the
mammals. For example, the vast majority of mammals – including
mice, humans and giraffes – have seven cervical vertebrae despite
obvious differences in body size and shape.
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